Improving the Prognosis of Congenital Heart Disease with Dr. Evan Zahn | Pioneers in Medicine

In this episode of “Pioneers in Medicine,” Evan Zahn, MD, one of the leading pediatric surgeons in the country and head of the congenital heart program at Cedars-Sinai, discusses how improvements in surgical techniques, pre- and post-operative care and anesthesiology have contributed to overall survivability and improved quality of life in those with congenital defects. He shares additional advances on the horizon, including a recently FDA-approved valve system he helped to develop.

Connect with us:


Cedars-Sinai is a leader in providing high-quality healthcare encompassing primary care, specialized medicine and research. Since 1902, Cedars-Sinai has evolved to meet the needs of one of the most diverse regions in the nation, setting standards in quality and innovative patient care, research, teaching and community service. Today, Cedars- Sinai is known for its national leadership in transforming healthcare for the benefit of patients. Cedars-Sinai impacts the future of healthcare by developing new approaches to treatment and educating tomorrow’s health professionals. Additionally, Cedars-Sinai demonstrates a commitment to the community through programs that improve the health of its most vulnerable residents.